单次、重复及维持性氯胺酮输注治疗难治性抑郁症：一项随机对照试验。
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
作者信息
Phillips Jennifer L, Norris Sandhaya, Talbot Jeanne, Birmingham Meagan, Hatchard Taylor, Ortiz Abigail, Owoeye Olabisi, Batten Lisa A, Blier Pierre
机构信息
Mood Disorders Research Unit, The Royal's Institute of Mental Health Research, Ottawa (Phillips, Norris, Talbot, Birmingham, Hatchard, Ortiz, Owoeye, Batten, Blier); the Department of Psychiatry, University of Ottawa (Phillips, Norris, Talbot, Owoeye, Blier); and the Department of Cellular and Molecular Medicine, University of Ottawa (Blier).
出版信息
Focus (Am Psychiatr Publ). 2020 Apr;18(2):236-243. doi: 10.1176/appi.focus.18206. Epub 2020 Apr 23.
Abstract
(Reprinted with permission from 2019; 176:401-409).
摘要
（经许可重印自《2019年；176：401 - 409》）
相似文献
1
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Focus (Am Psychiatr Publ). 2020 Apr;18(2):236-243. doi: 10.1176/appi.focus.18206. Epub 2020 Apr 23.
2
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29.
3
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
Neuropsychopharmacology. 2020 Mar;45(4):606-612. doi: 10.1038/s41386-019-0570-x. Epub 2019 Nov 23.
4
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
J Psychiatr Res. 2018 Nov;106:61-68. doi: 10.1016/j.jpsychires.2018.09.013. Epub 2018 Sep 25.
5
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5.
6
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
BMC Psychiatry. 2020 Jun 2;20(1):268. doi: 10.1186/s12888-020-02672-3.
7
Continuation phase intravenous ketamine in adults with treatment-resistant depression.
J Affect Disord. 2016 Dec;206:300-304. doi: 10.1016/j.jad.2016.09.008. Epub 2016 Sep 12.
8
Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior.
J Psychiatr Pract. 2018 Jul;24(4):279-291. doi: 10.1097/PRA.0000000000000316.
9
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
J Psychopharmacol. 2018 Oct;32(10):1118-1126. doi: 10.1177/0269881118798614. Epub 2018 Sep 27.
10
Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine.
Focus (Am Psychiatr Publ). 2020 Apr;18(2):181-192. doi: 10.1176/appi.focus.20190048. Epub 2020 Apr 23.
引用本文的文献
1
Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.
Eur Arch Psychiatry Clin Neurosci. 2024 Oct 28. doi: 10.1007/s00406-024-01925-6.
2
The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review.
Pharmaceutics. 2023 Dec 13;15(12):2773. doi: 10.3390/pharmaceutics15122773.
Zotero 插件